India Pharma Outlook Team | Friday, 22 May 2026
PMOS Explained: The New Health Term Replacing PCOS
The term Polyendocrine Metabolic Ovarian Syndrome (PMOS) is quickly gaining attention in the medical world as doctors and health experts push to replace the widely used term Polycystic Ovary Syndrome (PCOS).
The change is aimed at improving diagnosis, treatment, and awareness of a condition that affects millions of women globally.
According to doctors in Bengaluru, the new term better reflects the real nature of the disorder, which goes far beyond ovarian cysts and includes serious metabolic and hormonal issues.
Experts say PMOS gives a more accurate understanding of the condition compared to PCOS. Many women with the disorder often face delayed diagnosis because the older term focuses heavily on ovarian cysts, even though several patients do not show cysts during ultrasound scans. Doctors believe the updated terminology will help women receive early diagnosis and more targeted treatment.
The discussion around the name change recently gained momentum after global endocrinology experts proposed the shift during the European Congress of Endocrinology. The recommendation was also published in a leading medical journal, highlighting the growing international support for redefining the condition.
For years, PCOS has been one of the most misunderstood health conditions affecting women. The disorder is commonly associated with irregular periods, acne, facial hair growth, fertility problems, and weight gain. However, doctors say the name itself created confusion among patients because many women believed they could not have the condition without visible ovarian cysts.
Medical experts in Bengaluru explained that several women showing classic hormonal symptoms were incorrectly ruled out after normal ultrasound reports. This often delayed treatment and increased the risk of long-term complications.
The new term PMOS focuses on the metabolic and endocrine nature of the condition rather than only the ovaries. Doctors say this shift is important because the disorder is linked to insulin resistance, obesity, inflammation, diabetes risk, cardiovascular disease, fatty liver disease, and mental health concerns.
Also Read: AI-Augmented Clinical Trials & Drug Development Evolution in India
According to specialists, PMOS encourages doctors to evaluate the complete health profile of a patient. Instead of depending mainly on ultrasound scans, doctors are now emphasizing blood sugar levels, hormonal imbalance, cholesterol levels, blood pressure, liver function, menstrual history, and lifestyle-related symptoms.
Healthcare professionals believe this broader diagnostic approach will improve women’s health outcomes and reduce the chances of missed or delayed diagnosis.
Experts also emphasised that the renaming should encourage more comprehensive clinical assessment and diagnosis. "A PMOS diagnosis should never rely on a single investigation. It begins with a detailed clinical assessment, including menstrual history, symptoms of androgen excess such as acne or facial hair growth, weight patterns, and signs of insulin resistance," said Dr Sushma Krishnegowda, obstetrician and gynaecologist, Apollo Hospitals.
Doctors say one of the biggest advantages of using the term PMOS is increased awareness about the seriousness of the condition. While PCOS was often treated mainly as a reproductive or fertility issue, PMOS highlights its impact on the entire body.
Experts say early diagnosis is critical because untreated hormonal and metabolic disorders can lead to severe complications later in life. Many women with the condition are at higher risk of Type 2 diabetes, hypertension, infertility, depression, sleep disorders, and heart disease.
The updated terminology is also expected to reduce stigma and confusion among patients. Several women reportedly felt frustrated or misunderstood after being told they did not have PCOS simply because scans showed no cysts. Doctors believe PMOS creates a clearer and more scientifically accurate explanation for patients experiencing symptoms.
"The shift from PCOS to PMOS is not merely a change in terminology; it is a shift towards understanding women's health better and treating it more holistically," said Dr Priya SP Patil, consultant, obstetrician & gynaecologist, laparoscopic surgeon, infertility specialist, Altius Hospital, Rajajinagar.
Lifestyle management continues to remain a key part of treatment. Specialists recommend healthy eating habits, regular exercise, stress management, proper sleep, and routine health monitoring. In some cases, medications may also be prescribed to control insulin resistance, hormonal imbalance, or menstrual irregularities.
Medical experts say awareness campaigns and better public education will now play an important role in helping women recognize symptoms early and seek proper medical care.
Health experts estimate that PMOS, previously known as PCOS, affects nearly 10 percent to 13 percent of women of reproductive age worldwide. According to the World Health Organization, millions of women remain undiagnosed because symptoms are often misunderstood or ignored. Experts believe nearly 70 percent of affected women do not even know they have the condition.
Recent global studies estimate that more than 170 million women worldwide are living with PMOS/PCOS. The shift from PCOS to PMOS marks an important step in women’s healthcare. Doctors believe the new terminology can improve understanding of the disorder among patients, families, and healthcare providers while also encouraging a more comprehensive treatment approach.